These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 308618)

  • 21. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
    Lyles KW; Harrelson JM; Drezner MK
    J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353
    [No Abstract]   [Full Text] [Related]  

  • 22. Vitamin D metabolism in hypophosphatemic rickets.
    Mason RS; Rohl PG; Lissner D; Posen S
    Am J Dis Child; 1982 Oct; 136(10):909-13. PubMed ID: 6981996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone sensitivity in familial X-linked hypophosphatemic rickets.
    McElduff A; Posen S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):386-9. PubMed ID: 2753981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Scriver type autosomal hypophosphatemic rachitis: a family case].
    David L; Pesso JL; Cochat P; Plauchu H; François R
    Pediatrie; 1987; 42(7):563-8. PubMed ID: 2832821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biological and bone histomorphometric studies in hypophosphatemic vitamin-resistant rickets treated with 1,25-(OH)2D and phosphorus].
    Dumas R; Guermoud C; Garabedian M; Meunier JP
    Arch Fr Pediatr; 1985; 42(7):507-10. PubMed ID: 3002291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria.
    Chen C; Carpenter T; Steg N; Baron R; Anast C
    Pediatrics; 1989 Aug; 84(2):276-80. PubMed ID: 2787497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
    J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New developments in pharmacology of vitamin D.
    Med Lett Drugs Ther; 1974 Feb; 16(3):15-6. PubMed ID: 4358446
    [No Abstract]   [Full Text] [Related]  

  • 30. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
    Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
    J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum 1,25-dihydroxyvitamin D in bone disease.
    N Engl J Med; 1979 Feb; 300(8):434-5. PubMed ID: 759924
    [No Abstract]   [Full Text] [Related]  

  • 32. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extremely low serum pyridoxal 5'-phosphate in children with familial hypophosphatemic rickets.
    Reynolds RD; Lorenc RS; Wieczorek E; Pronicka E
    Am J Clin Nutr; 1991 Mar; 53(3):698-701. PubMed ID: 2000825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.
    Nakajima S; Yamaoka K; Yamamoto T; Okada S; Tanaka H; Seino Y
    Bone Miner; 1990 Sep; 10(3):201-9. PubMed ID: 2171704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypophosphatemia of a genetic origin].
    Escoubet B; Silve C
    Nephrologie; 1992; 13(3):115-21. PubMed ID: 1641053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment.
    Chaussain-Miller C; Sinding C; Septier D; Wolikow M; Goldberg M; Garabedian M
    Oral Dis; 2007 Sep; 13(5):482-9. PubMed ID: 17714351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and total 24,25-dihydroxyvitamin D in human serum.
    Parviainen MT; Savolainen KE; Alhava EM; Mäenpää PH
    Ann Clin Res; 1981 Feb; 13(1):26-33. PubMed ID: 6972726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypophosphatemic rickets accompanying congenital microvillous atrophy.
    Kagitani K; Yamamoto T; Miki K; Matsumoto S; Shima M; Tajiri H; Harada T; Okada S
    J Bone Miner Res; 1998 Dec; 13(12):1946-52. PubMed ID: 9844114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse.
    Meyer RA; Gray RW; Meyer MH
    Endocrinology; 1980 Nov; 107(5):1577-81. PubMed ID: 6893581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Fraser D; Kooh SW; Kind HP; Holick MF; Tanaka Y; DeLuca HF
    N Engl J Med; 1973 Oct; 289(16):817-22. PubMed ID: 4357855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.